Tradestie Institutional Equity Comparison Engine

OGEN vs PTN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTN Overall Edge

PTN Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palatin Technologies, Inc. (PTN) driven by superior Valuation, Momentum & Technical while OGEN counters with relative strength in Growth & Margin. Fundamentally, OGEN trades at N/M Forward P/E with 0.0% operating margin (-91.3% YoY revenue) versus PTN at 42.9x Forward P/E and -65.7% operating margin (-80.1% YoY). In options structure, OGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PTN
OGEN N/M vs PTN 42.9x Fwd P/E
Growth & Margin Winner OGEN
Op Margin 0.0% vs -65.7% ยท YoY -91.3% vs -80.1%
Momentum & Technical Winner PTN
1Y -82.6% vs -43.3% ยท 52W Pos 3% vs 6%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OGEN NYSE American
Oragenics Inc.
Pharmaceutical Preparations
$0.20
-1.49% 1D
Market Cap $906,903
1M Return -54.47%
1Y Return -82.63%
Forward P/E N/M
Unified AI Score
38.8 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 75.0
PTN US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap $11.1M
1M Return +1.74%
1Y Return -43.29%
Forward P/E 42.9x
Unified AI Score
31.5 / 100 SELL
Tech 15.0 Fund 30.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OGEN -82.63% PTN -43.29% Spread: +39.34 pp (PTN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period OGEN Revenue PTN Revenue OGEN Op. Margin PTN Op. Margin Margin Edge
FY2018 N/A $70M N/A 38.6% PTN
FY2019 N/A $60M N/A 59.3% PTN
FY2020 N/A $0M N/A -20007.6% PTN
FY2021 $0M N/A -18130.3% N/A OGEN
FY2022 $0M $0M -10964.6% -2491.6% PTN
FY2023 $0M $0M -55519.9% -668.7% PTN
FY2024 N/A $0M N/A -501.0% PTN
FY2026 N/A $10M N/A -65.7% PTN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OGEN (3) vs PTN (7)
Institutional Metric OGEN PTN Criterion Row Winner
Market Capitalization Scale $906,903 $11.1M Larger Scale PTN
Trailing P/E Ratio Valuation N/M 42.9x Lower Multiple PTN
Forward P/E Ratio Valuation N/M 42.9x Lower Multiple PTN
Revenue Growth (YoY) Growth -91.3% -80.1% Higher Growth PTN
Operating Margin (TTM) Profitability 0.0% -65.7% Higher Margin OGEN
Net Profit Margin Profitability 0.0% -63.5% Higher Margin OGEN
Return on Equity (ROE) Capital Efficiency -1307.1% -877.5% Higher ROE PTN
52-Week Range Position Momentum 3% ($0โ€“$1) 6% ($5โ€“$31) Stronger Trend PTN
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 153% Vol 0.87ฮฒ ยท 106% Vol Lower Realized Risk PTN
Unified Institutional Score Composite Signal 38.8 / 100 (SELL) 31.5 / 100 (SELL) Higher Composite OGEN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OGEN vs PTN Buy Guide
OGEN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OGEN nor PTN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.